READ: Prime/MRx presents at AMCP: real-world first year cost-effectiveness assessment of GLP-1s to treat non-diabetes obesity

This week at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting, Prime/MRx will present a number of research posters. Dive into this gold award-winning study to learn more about the changes in total cost of care (TCC) one year before and one year after initiation of GLP-1 treatment among commercially insured members with obesity, without diabetes, compared to a concurrent matched control group. Read the full research poster.